全球多发性硬化诊断障碍:来自国际多发性硬化联盟MS Atlas第三版的数据
国际多发性硬化联盟第三版Atlas of MS调查覆盖107个国家(约占全球人口82%),83%报告至少存在1项早期MS诊断的主要障碍,最常见为公众和医务人员对MS症状认识不足及缺乏有诊断知识的医务人员;34%仅使用2017年McDonald标准,66%报告采用该标准存在障碍;国家指南或诊断速度标准与障碍存在及2017标准实施无显著关联。
要点
- 107个国家中83%报告至少1项早期MS诊断主要障碍,公众和医务人员认识不足最常见。
- 34%仅使用2017年McDonald标准诊断,66%报告采用该标准存在至少1项障碍。
- 国家指南或诊断速度标准与早期诊断障碍及2017标准实施无显著关联。
核心结论
- 本研究发早期MS诊断存在普遍且一致的全球障碍,干预措施如开展可及的教育和培训可提供成本效益机会以改善早期MS诊断的可及性。
研究设计与样本
- 国际多发性硬化联盟第三版Atlas of MS调查,评估全球MS诊断现状,包括诊断标准采用、患者/医务人员/卫生系统层面的诊断障碍及国家指南或诊断速度标准的存在情况,共107个国家协调员参与,代表约82%的世界人口。
主要发现
- 83%报告至少1项早期MS诊断的主要障碍。
- 最常见的障碍包括:公众对MS症状缺乏认识(68%)、医务人员对MS症状缺乏认识(59%)、缺乏具备诊断MS知识的医务人员(44%)。
- 三分之一报告缺乏专科医疗设备或诊断检测。
- 34%报告仅使用2017年McDonald标准(McD-C)进行诊断,79%报告2017年McD-C为最常用标准。
- 66%报告采用2017年McD-C存在至少1项障碍,其中45%报告神经科医生缺乏认识或培训。
关键数值与推荐
- 国家指南或针对诊断速度的实践标准与早期MS诊断障碍的存在及2017年McD-C的实施之间无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Recent data suggest increasing global prevalence of multiple sclerosis (MS). Early diagnosis of MS reduces the burden of disability-adjusted life years and associated health care costs. Yet diagnostic delays persist in MS care and even within national health care systems with robust resources, comprehensive registries, and MS subspecialist referral networks. The global prevalence and characteristics of barriers to expedited MS diagnosis, particularly in resource-restricted regions, have not been extensively studied. Recent revisions to MS diagnostic criteria demonstrate potential to facilitate earlier diagnosis, but global implementation remains largely unknown. METHODS: The Multiple Sclerosis International Federation third edition of the Atlas of MS was a survey that assessed the current global state of diagnosis including adoption of MS diagnostic criteria; barriers to diagnosis with respect to the patient, health care provider, and health system; and existence of national guidelines or national standards for speed of MS diagnosis. RESULTS: Coordinators from 107 countries (representing approximately 82% of the world population), participated. Eighty-three percent reported at least 1 "major barrier" to early MS diagnosis. The most frequently reported barriers included the following: "lack of awareness of MS symptoms among general public" (68%), "lack of awareness of MS symptoms among health care professionals" (59%), and "lack of availability of health care professionals with knowledge to diagnose MS" (44%). One-third reported lack of "specialist medical equipment or diagnostic tests." Thirty-four percent reported the use of only 2017 McDonald criteria (McD-C) for diagnosis, and 79% reported 2017 McD-C as the "most commonly used criteria." Sixty-six percent reported at least 1 barrier to the adoption of 2017 McD-C, including "neurologists lack awareness or training" by 45%. There was no significant association between national guidelines pertaining to MS diagnosis or practice standards addressing the speed of diagnosis and presence of barriers to early MS diagnosis and implementation of 2017 McD-C. DISCUSSION: This study finds pervasive consistent global barriers to early diagnosis of MS. While these barriers reflected a lack of resources in many countries, data also suggest that interventions designed to develop and implement accessible education and training can provide cost-effective opportunities to improve access to early MS diagnosis.
引用
- Solomon AJ, Marrie RA, Viswanathan S, et al. Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition. Neurology. 2023. PMID: 37321866. doi:10.1212/WNL.0000000000207481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。